47 completed, 13 terminated, 6 withdrawn, 4 active not recruiting. 41 Not applicable, 17 Phase 2, 5 Phase 1, 3 Early Phase 1, 3 Phase 3.
Follow Stage IA Breast Cancer: new trials by email Literature Review of Stage IA Breast Cancer trials Research Report on Stage IA Breast Cancer
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Hypofractionated Radiation Therapy vs Standard Treatment in Breast Cancer. Hypofractionated radiotherapy - Ductal Breast Carcinoma in Situ, Invasive Breast Cancer | Not applicable | Active not recruiting | Coordinación de Investigación en Salud, Mexico | 72 | 2021-04-26 | 2026-03-23 |
| Exercise Intervention in Targeting Adiposity and Inflammation With Movement to Improve Prognosis in Breast Cancer Exercise Intervention, Informational Intervention, Laboratory Biomarker Analysis - Cancer Survivor, Central Obesity | Not applicable | Withdrawn | University of Southern California | 2019-07-29 | 2019-10-24 | |
| Endocrine Therapy in Treating Patients With HER2 Negative, Low Risk Breast Cancer Anastrozole, Exemestane, Laboratory Biomarker Analysis - HER2/Neu Negative, Invasive Breast Carcinoma | Phase 4 | Withdrawn | Fred Hutchinson Cancer Center | 2018-09-01 | 2018-12-27 | |
| Hypofractionated Radiation Therapy in Treating Patients With Stage 0-IIB Breast Cancer Hypofractionated Radiation Therapy - Ductal Breast Carcinoma In Situ, Invasive Breast Carcinoma | Phase 2 | Completed | University of Utah | 102 | 2017-12-12 | 2025-12-30 |
| Intraoperative Electron Beam Radiotherapy Boost in Treating Patients With Stage I-II Breast Cancer Undergoing Surgery With Reconstruction Electron Beam Therapy, Lumpectomy, Quality-of-Life Assessment - Stage IA Breast Cancer, Stage IB Breast Cancer | Phase 2 | Active not recruiting | Ohio State University Comprehensive Cancer Center | 108 | 2017-10-16 | 2026-06-03 |
| Exercise in Targeting Metabolic Dysregulation in Stage I-III Breast or Prostate Cancer Survivors Exercise Intervention, Laboratory Biomarker Analysis, Polar heart rate monitor - Cancer Survivor, No Evidence of Disease | Not applicable | Terminated | University of Southern California | 23 | 2017-08-17 | 2025-09-29 |
| Copanlisib, Letrozole, and Palbociclib in Treating Patients With Hormone Receptor Positive HER2 Negative Stage I-IV Breast Cancer Biopsy of Breast, Copanlisib, Laboratory Biomarker Analysis - Estrogen Receptor Positive, HER2/Neu Negative | Phase 1 | Terminated | Jonsson Comprehensive Cancer Center | 10 | 2017-08-02 | 2022-09-26 |
| Ultrasound in Detecting Taxane-Induced Neuropathy in Patients With Breast Cancer Biopsy, Questionnaire Administration, Ultrasound Tomography - Peripheral Neuropathy, Stage 0 Breast Cancer | Not applicable | Completed | Wake Forest University Health Sciences | 20 | 2017-05-11 | 2024-04-08 |
| Mindfulness Meditation or Survivorship Education in Improving Behavioral Symptoms in Younger Stage 0-III Breast Cancer Survivors (Pathways to Wellness) Educational Intervention, Laboratory Biomarker Analysis, Meditation Therapy - Cancer Survivor, Early-Stage Breast Carcinoma | Not applicable | Unknown | Jonsson Comprehensive Cancer Center | 96 | 2017-02-20 | 2022-07-21 |
| Endocrine Therapy Fulvestrant & Palbociclib or Aromatase Inhibitor Therapy in Treating Older Patients With Hormone Responsive Breast Cancer That Cannot Be Removed by Surgery Fulvestrant, Laboratory Biomarker Analysis, Palbociclib - Estrogen Receptor and/or Progesterone Receptor Positive, HER2/Neu Negative | Phase 2 | Completed | Ohio State University Comprehensive Cancer Center | 14 | 2017-02-16 | 2025-12-19 |
| S1415CD, Trial Assessing CSF Prescribing Effectiveness and Risk (TrACER) Preventive Intervention, Quality-of-Life Assessment, Questionnaire Administration - Febrile Neutropenia, Stage 0 Breast Cancer | Not applicable | Completed | SWOG Cancer Research Network | 3665 | 2016-10-07 | 2022-10-20 |
| MRI and Cardio-Pulmonary Exercise Testing in Evaluating Exercise Intolerance in Patients With Stage I-III Breast Cancer After Chemotherapy Treatment Cardiopulmonary Exercise Testing, Magnetic Resonance Imaging - Healthy Subject, Stage IA Breast Cancer | Completed | Wake Forest University Health Sciences | 33 | 2016-08-25 | 2019-04-26 | |
| Functional Magnetic Resonance Imaging in Assessing Affect Reactivity and Regulation in Patients With Stage 0-III Breast Cancer Biospecimen Collection, Functional Magnetic Resonance Imaging, Questionnaire Administration - Healthy Subject, Stage 0 Breast Cancer | Completed | Stanford University | 178 | 2016-08-01 | 2022-07-27 | |
| Survivorship Care Plan in Promoting Physical Activity in Breast or Colorectal Cancer Survivors in Wisconsin Educational Intervention, Internet-Based Intervention, Monitoring Device - Cancer Survivor, Healthy Subject | Not applicable | Completed | University of Wisconsin, Madison | 100 | 2016-07-01 | 2019-11-18 |
| Computerized Cognitive Retraining in Improving Cognitive Function in Breast Cancer Survivors Computer-Assisted Cognitive Training, Questionnaire Administration, Standard Follow-Up Care - Cancer Survivor, Stage 0 Breast Cancer | Not applicable | Completed | Fred Hutchinson Cancer Center | 15 | 2016-05-01 | 2017-12-13 |
| Intensity Modulated Accelerated Partial Breast Irradiation Before Surgery in Treating Older Patients With Hormone Responsive Stage 0-I Breast Cancer accelerated partial breast irradiation, intensity-modulated radiation therapy, image-guided radiation therapy - Estrogen Receptor-positive Breast Cancer, Invasive Ductal Breast Carcinoma | Not applicable | Completed | Ohio State University Comprehensive Cancer Center | 22 | 2016-04-29 | 2025-09-22 |
| Pancreatic Nutritional Program for Weight Loss in Overweight/Obese Patients With Stage I-III Breast Cancer Dietary Intervention, Educational Intervention, Laboratory Biomarker Analysis - Obesity, Stage IA Breast Cancer | Not applicable | Completed | City of Hope Medical Center | 21 | 2016-03-22 | 2026-10-01 |
| eHealth Weight Loss Program in African American Breast Cancer Survivors Behavioral Dietary Intervention, Exercise Intervention, Activity Monitoring Device - Cancer Survivor, Stage IA Breast Cancer | Not applicable | Completed | Rutgers, The State University of New Jersey | 35 | 2016-01-08 | 2021-04-13 |
| Attitudes, Beliefs, and Preferences of Older Stage I-III Breast Cancer Survivors Towards Physical Activity One-on-one interview, Survey Questions - Cancer Survivor, Stage IA Breast Cancer | Not applicable | Completed | Case Comprehensive Cancer Center | 61 | 2015-10-14 | 2020-01-03 |
| Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy Telapristone Acetate, Placebo, Laboratory Biomarker Analysis - BRCA1 Mutation Carrier, BRCA2 Mutation Carrier | Phase 2 | Completed | Northwestern University | 67 | 2015-10-01 | 2023-02-22 |
Showing 20 of 73. Sign in to see all of them.
Breast Neoplasms (73) · Breast Carcinoma In Situ (19) · Carcinoma, Intraductal, Noninfiltrating (15) · Breast Neoplasms, Male (6) · Depression (6) · Carcinoma, Ductal, Breast (5) · Triple Negative Breast Neoplasms (5) · Colorectal Neoplasms (4) · Anxiety Disorders (3) · Peripheral Nervous System Diseases (3) · Prostatic Neoplasms (3) · Carcinoma, Lobular (2) · Obesity (2) · Ovarian Neoplasms (2) · Stomach Neoplasms (2)
Breast Diseases (73) · Neoplasms (73) · Neoplasms by Site (73) · Skin Diseases (73) · Skin and Connective Tissue Diseases (73) · Carcinoma (29) · Neoplasms by Histologic Type (29) · Neoplasms, Glandular and Epithelial (29) · Carcinoma in Situ (25) · Adenocarcinoma (18) · Neoplasms, Ductal, Lobular, and Medullary (17) · Behavior (7) · Behavioral Symptoms (6) · Breast Carcinoma In Situ (6) · Pathological Conditions, Signs and Symptoms (6)
Early Intervention, Educational (8) · Methods (8) · Magnetic Resonance Spectroscopy (7) · Taxes (6) · Trastuzumab (6) · Cyclophosphamide (5) · Educational Status (5) · Radiotherapy (5) · Paclitaxel (4) · Radiation (4) · Biopsy (3) · Counseling (3) · Doxorubicin (3) · Fish Oils (3) · Immunohistochemistry (3)
University of Southern California (10) · Ohio State University Comprehensive Cancer Center (9) · Wake Forest University Health Sciences (7) · National Cancer Institute (NCI) (5) · Northwestern University (4) · Rutgers, The State University of New Jersey (4) · University of Washington (4) · City of Hope Medical Center (3) · Fred Hutchinson Cancer Center (2) · Jonsson Comprehensive Cancer Center (2) · Roswell Park Cancer Institute (2) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (2) · Stanford University (2) · University of Nebraska (2) · Alliance for Clinical Trials in Oncology (1)
United States (70) · Canada (2) · Puerto Rico (2) · Mexico (1) · Switzerland (1)
Dennis Holmes (2) · Joanne Mortimer (2) · Agustin Garcia, MD (1) · Aman Buzdar (1) · Amulya C Yellala, MD (1) · Andrea Barsevick, PhD (1) · Anna Wu (1) · Antoinette Tan (1) · Arthur Blackstock (1) · Ayca Gucalp (1) · Bhuvaneswari Ramaswamy, MD (1) · Bruce Haffty, MD (1) · Cheryl Koopman (1) · Christina Dieli-Conwright (1) · Christina Dieli-Conwright, Ph.D. (1)
PMID 24095609, PMID 24239210, PMID 24881463, PMID 25495490, PMID 26006067, PMID 26092816, PMID 26276750, PMID 27022111, PMID 27044936, PMID 28453704, PMID 28560655, PMID 28911092, PMID 29233615, PMID 29863451, PMID 29961039, PMID 30193295, PMID 30535101, PMID 30549145, PMID 30611839, PMID 30971205, PMID 31236810, PMID 31269914, PMID 31618131, PMID 32808383, PMID 34018031, PMID 34406839, PMID 35365139, PMID 35795051, PMID 36130057, PMID 36228177, PMID 36279134, PMID 36493334, PMID 36521078, PMID 36943254, PMID 37083300, PMID 37770704, PMID 37788414, PMID 38917400, PMID 39132946, PMID 40132910, PMID 40314623, PMID 40986647, PMID 41170811, PMID 41637791
P30CA012197 (6), P30CA014089 (5), P30CA015704 (4), P30CA016056 (2), P30CA036727 (2), P30CA072720 (2), 2004 (1), K07CA148888 (1), N01CM62204 (1), N01CN00034 (1), N01CN35159 (1), P30CA006927 (1), P30CA013330 (1), P30CA014520 (1), P30CA016672 (1)